Status:
RECRUITING
Project CONTINUITY: Promoting Evidence-Based Cancer Screening Among Underserved Women
Lead Sponsor:
University of Florida
Conditions:
Cervical Cancer Screening Methods
Eligibility:
FEMALE
25-65 years
Brief Summary
Project CONTINUITY (Connecting You to Care in the Community) was developed to increase adherence to cervical cancer screening regimens from initial screening to needed follow-up care by (1) providing ...
Detailed Description
The purpose of this pilot project is to gather information about the extent to which women residing in high SEV neighborhoods who choose HPV self-sampling relative to in-clinic Pap/HPV testing adhere ...
Eligibility Criteria
Inclusion
- Using the American Cancer Society (ACS) screening recommendations, adults 25 to 65 will be eligible.
- Assigned sex at birth is female
- No previous history of cervical cancer
- No previous history of a hysterectomy
- Not currently pregnant (self-report)
- Not currently menstruating\*
- Have not used any vaginal products (e.g., oil-based lubricants, antifungal, and douches) in prior 2 days\*. Use of vaginal contraceptives, condoms and water-based lubricants are allowed.
- Have not given birth in the prior 12 weeks\*
- Self-report they have not undergone cancer screening in the past 4 years or more OR report being past due according to provider recommended screening schedule.
- Self-report of using the MOC in the past, no current usual source of care OR usual source of care is a non-UFH provider and/or cervical cancer screening is not accessible through that provider
- Reside in census tracts where the Mobile Outreach Clinic travels.
- Have a mobile phone or access to a mobile phone that can be used to receive messages or a valid email address.
Exclusion
- For patients who are excluded for criterion 6, 7, and 8, the outreach team (community clinical navigator and CHW) will ask the participant if they can be re-contacted for potential future study eligibility assessment. If the participant agrees, the navigator or CHW will collect contact information to re-contact the participant at a later (pre-determined) date up to 20 weeks later for eligibility screening.
Key Trial Info
Start Date :
June 7 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT05390567
Start Date
June 7 2024
End Date
December 1 2027
Last Update
July 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Gainesville, Florida, United States, 32610